Carlos S. Cerski
Porto Alegre, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Probiotics and intestinal permeability in adults with metabolic dysfunction-associated steatohepatitis: A secondary analysis of a randomized clinical trial.
Journal: JPEN. Journal of parenteral and enteral nutrition
Published: October 14, 2025
Evaluation of the Variability in Selenoprotein Genes in Hepatocellular Carcinoma Patients.
Journal: Biochemical genetics
Published: March 25, 2025
Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model.
Journal: Biomedical reports
Published: April 08, 2024
Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial.
Journal: Frontiers in nutrition
Published: December 28, 2023
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease.
Journal: World journal of hepatology
Published: November 03, 2023
Potential Beneficial Effect of Rifaximin in the Prevention of Hepatocellular Carcinoma through the Modulation of the Microbiota in an Experimental Model of Non-alcoholic Fatty Liver Disease.
Journal: Acta gastroenterologica Latinoamericana
Published: June 10, 2023
Marginal Ulcer Incidence and the Population of Gastrin Producing G cells Retained in the Gastric Pouch after Roux-en-Y Gastric Bypass: Is There a Relationship?
Journal: Obesity surgery
Published: February 19, 2023
Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet-induced obesity in rats.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: November 08, 2022
Clinical outcomes and prognostic factors of head and neck squamous cell carcinoma: a ten-year follow-up study.
Journal: Brazilian oral research
Published: October 18, 2022
Protocols of Investigation of Neonatal Cholestasis-A Critical Appraisal.
Journal: Healthcare (Basel, Switzerland)
Published: August 29, 2022
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study.
Journal: Annals of hepatology
Published: July 21, 2022
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: July 04, 2022
Last Updated: 09/26/2026